FOXO_OUT_1 [2025-05-06 09:35:01 -0400] 2234 Bytes | 487 tokens | Cum: 487 tkns (6.09% of 8k)
==========================================================================

Adventure stirs the soul. 9:35 AM on Tue May 06, 2025, FOXO Technologies (FOXO) is on the move—$0.6361 to $2.12. Shall we explore the opportunity, or stand down? Analysis awaits.

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for FOXO Technologies (FOXO).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.

Your task is to analyze news, filings, fundamentals, and trading data to prepare evidence-based insights on company summary, price target, squeeze potential, sentiment, catalyst, ethical rating, market momentum, stability, and improvement suggestions. The final prompt will present an opportunity to answer these.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You can request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

--- COMPANY PROFILE ---
Company: FOXO Technologies (FOXO)
IPO: 2022-09-19 (2 Years Ago)
Market Cap: $3,387,594
Shares Outstanding: 3,870,000
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange: XASE
Description: FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. The company's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life. The Company manages and classifies its business into two reportable business segments: Healthcare; and Labs and Life.

If you're ready to see some news headlines, just say: `YES`.

FOXO_OUT_3 [2025-05-06 09:35:02 -0400] 251 Bytes | 78 tokens | Cum: 566 tkns (7.07% of 8k)
==========================================================================

You just read a chunk of A1.
You may now:
- Say "MOR" to continue this article
- Say "A2", "A3", etc. to request another
- Or say "NEX" to move to the next source

You are allowed up to 3 articles from this list. If you’re ready to move on, say NEX.

FOXO_OUT_5 [2025-05-06 09:35:03 -0400] 2295 Bytes | 733 tokens | Cum: 1302 tkns (16.28% of 8k)
==========================================================================

Today 08:05AM - FOXO TECHNOLOGIES INC.'S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
Apr-29-25 10:05AM - FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
Apr-17-25 05:00PM - FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
Apr-16-25 05:45PM - FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K
Mar-19-25 08:07AM - FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
Mar-12-25 08:10AM - FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
Feb-24-25 08:10AM - FOXO TECHNOLOGIES, INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR TWO ASSISTED-LIVING FACILITIES IN FLORIDA FOR A TOTAL CONSIDERATION OF $60 MILLION

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-04-16T21:45:00Z - FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K
B2 - 2025-02-24T21:24:29Z - What's Going On With FOXO Shares Monday?
B3 - 2024-06-14T12:30:00Z - FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.
B4 - 2024-04-23T21:00:00Z - FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
B5 - 2024-02-14T14:32:00Z - FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global
B6 - 2023-12-04T18:10:23Z - Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B7 - 2023-12-04T13:00:51Z - Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
B8 - 2023-09-18T17:25:03Z - Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B9 - 2023-09-18T12:10:35Z - Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket
B10 - 2023-09-07T17:19:11Z - Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FOXO_OUT_7 [2025-05-06 09:35:04 -0400] 923 Bytes | 263 tokens | Cum: 1567 tkns (19.59% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/04/16/3062961/0/en/FOXO-TECHNOLOGIES-INC-ANNOUNCES-FILING-OF-ITS-ANNUAL-REPORT-ON-FORM-10-K.htmlFOXO Technologies Inc. has filed its 2024 Annual Report on Form 10-K, which includes an audit opinion with an explanatory paragraph related to the company's ability to continue as a going concern. The company has completed acquisitions of Myrtle Recovery Centers and Rennova Community Health, and believes it is well-positioned for growth in 2025.

Respond with ONE of the following (3 characters max):
- `MOR` for the next chunk of this item
- `NEX` to move on to the next set of data
- `XX` Get another document from the list above (e.g., A1, B4, S3)
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

FOXO_OUT_9 [2025-05-06 09:35:04 -0400] 1151 Bytes | 307 tokens | Cum: 1876 tkns (23.45% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-29 8-K Item 7.01 Regulation FD Disclosure.

On April 29, 2025, FOXO Technologies Inc., a Delaware corporation (the Company ), issued a press release which announced the completion of a reverse split with a ratio of 10:1, which was effective April 28, 2025 at 4:01 pm Eastern Time. A cop...

S2 - 2025-04-17 8-K Item 7.01 Regulation FD Disclosure.

On April 17, 2025, FOXO Technologies Inc., a Delaware corporation (the Company ), issued a press release which announced that, pursuant to shareholder approval received on November 29, 2024 of a reverse stock split of the Companys issued and ...

S3 - 2025-04-16 8-K Item 7.01 Regulation FD Disclosure.

On April 16, 2025, FOXO Technologies Inc., a Delaware corporation (the Company ), issued a press release which announced the filing of its Annual Report on Form 10-K for the year ended December 31, 2024. A copy of the press release is attache...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

FOXO_OUT_11 [2025-05-06 09:35:05 -0400] 1204 Bytes | 301 tokens | Cum: 2179 tkns (27.24% of 8k)
==========================================================================

Showing S1 (chunk 1 of 3): S1:
Item 7.01 Regulation FD Disclosure.

On April 29, 2025, FOXO Technologies Inc., a Delaware corporation (the Company ), issued a press release which announced the completion of a reverse split with a ratio of 10:1, which was effective April 28, 2025 at 4:01 pm Eastern Time. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed filed for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of thi

Respond with ONE of the following (3 characters max):
- `MOR` for the next chunk of this item
- `NEX` to move on to the next set of data
- `XX` Get another document from the list above (e.g., A1, B4, S3)
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

FOXO_OUT_13 [2025-05-06 09:35:06 -0400] 1204 Bytes | 259 tokens | Cum: 2440 tkns (30.50% of 8k)
==========================================================================

Showing S1 (chunk 2 of 3): s Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that the dissemination of such information is required by Regulation FD.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements. Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as if, may, should, expects, plans, anticipates, believes, estimates, predicts, potential or continue or the negative of these terms or other comparable terminology. These forward-looking statements are based on information currently available to the Companys management as well as estimates and assump

Respond with ONE of the following (3 characters max):
- `MOR` for the next chunk of this item
- `NEX` to move on to the next set of data
- `XX` Get another document from the list above (e.g., A1, B4, S3)
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

FOXO_OUT_15 [2025-05-06 09:35:06 -0400] 1050 Bytes | 225 tokens | Cum: 2667 tkns (33.34% of 8k)
==========================================================================

Showing S1 (chunk 3 of 3): tions made by its management and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause the Companys or its industrys actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. These forward-looking statements are made as of the date of this Current Report on Form 8-K, and the Company does not undertake an obligation to update these forward-looking statements after such date....

Respond with ONE of the following (3 characters max):
- `MOR` for the next chunk of this item
- `NEX` to move on to the next set of data
- `XX` Get another document from the list above (e.g., A1, B4, S3)
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

FOXO_OUT_17 [2025-05-06 09:35:18 -0400] 6114 Bytes | 1596 tokens | Cum: 4265 tkns (53.31% of 8k)
==========================================================================

This is our set of metrics for FOXO Technologies.
Please analyze the numbers.

+---------------------+-----------------------+-------------------------+-------------------------+
| Volume: 0 | Perf Month: -56.13% | Option/Short: No / No | Sales Y/Y TTM: 1397.08% |
+---------------------+-----------------------+-------------------------+-------------------------+
| Avg Volume: 726.28K | Perf Quarter: -76.73% | Short Float: 8.08% | ROE: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| Rel Volume: 0.00 | Index: - | Short Ratio: 0.39 | ROI: -253.21% |
+---------------------+-----------------------+-------------------------+-------------------------+
| RSI (14): 26.02 | Market Cap: 2.46M | Short Interest: 0.28M | Sales Surprise: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| ATR (14): 0.20 | Shs Outstand: 3.87M | Beta: 3.55 | EPS Surprise: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA20: -41.56% | Shs Float: 3.52M | Sales Q/Q: 4624.03% | P/E: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA50: -56.57% | Inst Own: 1.70% | Sales past 5Y: -634.35% | Earnings: - |
+---------------------+-----------------------+-------------------------+-------------------------+
| SMA200: -73.64% | Insider Own: 8.92% | Employees: - | |
+---------------------+-----------------------+-------------------------+-------------------------+
| Perf Week: -24.36% | Insider Trans: 0.00% | Debt/Eq: 1.37 | |
+---------------------+-----------------------+-------------------------+-------------------------+

The next section covers any insider trading by FOXO Technologies officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 2.12
Average Volume: 5388574.79
30-Day High: 2.12
30-Day Low: 0.6361

[Detailed Financials: Q3 2024]
- Total Assets: $42,671,000.00
- Total Liabilities: $60,225,000.00
- Total Equity: $-17,554,000.00
- Current Assets: $2,909,000.00
- Current Liabilities: $34,347,000.00

[Income Statement: Q3 2024]
- Revenue: $1,196,000.00
- Net Income: $-1,953,000.00
- Gross Profit: N/A
- Operating Income: $-1,005,000.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $1,571,000.00

[Detailed Financials: Q1 2024]
- Total Assets: $2,994,000.00
- Total Liabilities: $17,931,000.00
- Total Equity: $-14,937,000.00
- Current Assets: $262,000.00
- Current Liabilities: $17,072,000.00

[Income Statement: Q1 2024]
- Revenue: $7,000.00
- Net Income: $-2,160,000.00
- Gross Profit: N/A
- Operating Income: $-1,179,000.00
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q1 2024]
- Net Cash Flow: $-406,000.00
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of FOXO Technologies (FOXO).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about FOXO Technologies based on the provided news, filings, fundamentals, and trading metrics.

2) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, FOXO could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect FOXO to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

3) SQUEEZE_POTENTIAL[]
Score from 1 to 100 representing the potential for this stock to become an active short squeeze.
Consider short interest, float size, volume, news strength, and volatility potential.

4) TAGS[]
List 3–6 comma-separated descriptive tags (e.g., biotech, earnings beat, squeeze setup).

5) STOCK_TYPE[]
Choose one: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

6) PRIMARY_CATALYST[]
Specify the key recent or upcoming catalyst (e.g., earnings report, FDA approval, news).

7) SENTIMENT[]
Choose: bullish, bearish, neutral, or mixed.

8) ETHICAL_RATING[]
Objectively grade FOXO Technologies from A (high alignment) to F (low alignment) based on insider actions, dilution history, public follow-through, and executive practices.

9) UPCOMING_CATALYST[]
List any known upcoming events that could materially impact FOXO's share price.

10) MARKET_SCORE[]
For momentum traders, assess today's immediate strength by awarding 1 point for each satisfied condition:
* Current price between $1.50 and $20.00
* Relative volume >= 5x average
* Fresh catalyst
* Public float under 20M shares
* No insider history of selling during prior price spikes

Calculate:
Market Score = (Points/5) × 100
Return as MARKET_SCORE[XX]

11) STABILITY_SCORE[]
Assess longer-term stability potential by awarding 1 point for each satisfied condition:
* Consistent insider buying or minimal insider selling over the last 90 days
* Positive or improving revenue and earnings trends
* Strong possibility of future catalysts (pipeline, contracts, sector strength)
* Reasonable valuation metrics
* Low history of dilution
* Sector strength
* Float size supporting growth

Calculate:
Stability Score = (Points/7) × 100
Return as STABILITY_SCORE[YY]

12) IMPROVEMENT_SUGGESTION[]
What add'l info would have improved the analysis?

Return only FIELD[value] for all items.
Take your best guess if necessary, but do not leave any fields blank.
Do not explain your answers.

Finally, thanks for your awesome work!

FOXO_IN_19 [2025-05-06 09:35:19 -0400] 126 Bytes | 29 tokens | Cum: 4561 tkns (57.01% of 8k)
==========================================================================

====================================
[2025-05-06 09:35:19] # Analysis Completed
Elapsed Time: 18.88 seconds